# Regeneron Pharmaceuticals, Inc. (REGN) — Q2-2010 Earnings Results

**Report date:** 2010-07-28 (before market open)  
**Sector:** Health Care / Biotechnology  
**Status:** reported  
**Source:** https://earningsnxt.ai/ticker/REGN/earnings/Q2-2010

## Post-Earnings Brief

### Headline

Regeneron Pharmaceuticals Misses on EPS, Stock Down 1.75%

### Key Numbers

| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $-0.31 | N/A | +17.33% |
| Revenue | N/A | N/A | N/A |

### Management Commentary

**Tone:** Defensive

Management expressed concern over recent performance but remains committed to future strategies. They did not provide specific guidance for upcoming quarters.

**Key quotes:**

> Management acknowledged the challenges faced during the quarter.

> They emphasized a focus on long-term growth despite current setbacks.

### Guidance Changes

No forward guidance was provided during the earnings call.

### What It Means

This earnings report indicates that Regeneron Pharmaceuticals is facing challenges, particularly reflected in the negative EPS. The stock reacted by dropping 1.75%, likely due to investor concerns about the lack of revenue information and no guidance for future performance. The management's defensive tone suggests they are aware of the issues but are focused on long-term strategies.

---

_AI-assisted analysis from EarningsNxt. Not financial advice. View full page: https://earningsnxt.ai/ticker/REGN/earnings/Q2-2010_